Search

Your search keyword '"Beccacece, Alessia"' showing total 7 results
Start Over Author "Beccacece, Alessia" Publisher mdpi ag
7 results on '"Beccacece, Alessia"'

1. Predictors of Mortality and Orotracheal Intubation in Patients with Pulmonary Barotrauma Due to COVID-19: An Italian Multicenter Observational Study during Two Years of the Pandemic

Author

Tetaj, Nardi, primary, De Pascale, Gennaro, additional, Antonelli, Massimo, additional, Vargas, Joel, additional, Savino, Martina, additional, Pugliese, Francesco, additional, Alessandri, Francesco, additional, Giordano, Giovanni, additional, Tozzi, Pierfrancesco, additional, Rocco, Monica, additional, Biava, Anna Maria, additional, Maggi, Luigi, additional, Pisapia, Raffaella, additional, Fusco, Francesco Maria, additional, Stazi, Giulia Valeria, additional, Garotto, Gabriele, additional, Marini, Maria Cristina, additional, Piselli, Pierluca, additional, Beccacece, Alessia, additional, Mariano, Andrea, additional, Giancola, Maria Letizia, additional, Ianniello, Stefania, additional, Vaia, Francesco, additional, Girardi, Enrico, additional, Antinori, Andrea, additional, Bocci, Maria Grazia, additional, Marchioni, Luisa, additional, and Nicastri, Emanuele, additional

Published
2024
Full Text
View/download PDF

2. Evaluation of Cross-Immunity to the Mpox Virus Due to Historic Smallpox Vaccination

Author

Matusali, Giulia, primary, Petruccioli, Elisa, additional, Cimini, Eleonora, additional, Colavita, Francesca, additional, Bettini, Aurora, additional, Tartaglia, Eleonora, additional, Sbarra, Settimia, additional, Meschi, Silvia, additional, Lapa, Daniele, additional, Francalancia, Massimo, additional, Bordi, Licia, additional, Mazzotta, Valentina, additional, Coen, Sabrina, additional, Mizzoni, Klizia, additional, Beccacece, Alessia, additional, Nicastri, Emanuele, additional, Pierelli, Luca, additional, Antinori, Andrea, additional, Girardi, Enrico, additional, Vaia, Francesco, additional, Sette, Alessandro, additional, Grifoni, Alba, additional, Goletti, Delia, additional, Puro, Vincenzo, additional, and Maggi, Fabrizio, additional

Published
2023
Full Text
View/download PDF

5. Expansion of Myeloid Derived Suppressor Cells Contributes to Platelet Activation by L-Arginine Deprivation during SARS-CoV-2 Infection

Author

Sacchi, Alessandra, primary, Grassi, Germana, additional, Notari, Stefania, additional, Gili, Simona, additional, Bordoni, Veronica, additional, Tartaglia, Eleonora, additional, Casetti, Rita, additional, Cimini, Eleonora, additional, Mariotti, Davide, additional, Garotto, Gabriele, additional, Beccacece, Alessia, additional, Marchioni, Luisa, additional, Bibas, Michele, additional, Nicastri, Emanuele, additional, Ippolito, Giuseppe, additional, and Agrati, Chiara, additional

Published
2021
Full Text
View/download PDF

6. Efficacy of a Multistrain Synbiotic Treatment in Acute and Post-Acute COVID-19 Patients: A Double-Blind, Placebo-Controlled Randomized Trial.

Author

Giancola ML, Fontana A, Panebianco C, Mazzarelli A, Beccacece A, De Marco P, Cocomazzi G, De Giuli C, Grassi G, Fontana C, Baldini GM, Contu V, Copetti M, Perri F, Nicastri E, and Pazienza V

Abstract

Background and Aims: Several studies reported the effect of COVID-19 on inducing gut dysbiosis, which is also correlated with disease severity. This study aims to investigate the effect of a nutraceutical formula on the shift of microbiota profiles and, secondly, on the clinical-pathological parameters of acute and post-acute COVID-19 patients., Methods: In this randomised, double-blind, placebo-controlled trial conducted at National Institute for Infectious diseases (INMI) Lazzaro Spallanzani (Italy), 52 patients were randomly assigned (1:1) to receive a multistrain synbiotic formula (Kebirah ® ) or placebo orally for 35 days at COVID-19 diagnosis. Health professionals, investigators, and patients were masked to group assignments. The V3-V4 hypervariable region of 16S rRNA gene sequencing was employed to study the gut microbiota composition in the two groups., Results: Supplementation with Kebirah ® prevented the decrease in the Shannon diversity index of gut microbiota, which was instead observed in patients receiving the placebo. In addition, decreases in lymphocyte count and haemoglobin levels were observed only in the placebo group and not in the treated group, which was also characterised by an amelioration of the gut microbial profile, with an enrichment in beneficial bacteria and a preservation of species diversity., Conclusions: Our data suggest that modulating the gut microbiota in acute disease through administration of a specific symbiotic formula could be a useful strategy in the frame of SARS-CoV-2 infections.

Published
2024
Full Text
View/download PDF

7. Drug Policies Skyline during COVID-19 Pandemic.

Author

Vita S, Forliano D, De Luca A, Beccacece A, Marchioni L, Nicastri E, and On Behalf Of The Covid-Inmi Study Group

Abstract

The COVID-19 pandemic has produced an extraordinary care setting where physicians played, and continue to play, a critical role in containing viral spread and treating affected patients. Frontline workers have been receiving day-to-day new information about therapeutic advances. The purpose of the study is to analyse COVID-19 drug consumption trends in both acute and intensive care settings comparing Defined Daily Doses and the release of scientific clinical data from January to December 2020.

Published
2021
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results